mifepristone has been researched along with Blastocyst Disintegration in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atrio, J; Chen, M; Harvie, HS; Koelper, N; Loza-Avalos, SE; Nagendra, D; Schreiber, CA; Sonalkar, S | 1 |
| Li, C; Liu, X; Zhang, T; Zhou, L | 1 |
| Aisemberg, J; Bariani, MV; Billi, SC; Franchi, AM; Vercelli, CA; Wolfson, ML | 1 |
| Bardin, CW; Kaplan-Kraicer, R; Kostovetsky, I; Shalgi, R | 1 |
1 trial(s) available for mifepristone and Blastocyst Disintegration
| Article | Year |
|---|---|
Cost-effectiveness of Mifepristone Pretreatment for the Medical Management of Nonviable Early Pregnancy: Secondary Analysis of a Randomized Clinical Trial.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Cost-Benefit Analysis; Embryo Loss; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies | 2020 |
3 other study(ies) available for mifepristone and Blastocyst Disintegration
| Article | Year |
|---|---|
Effect of Irisin on LIF and integrin αvβ3 in rats of implantation failure.
Topics: Animals; Embryo Implantation; Embryo Loss; Endometrium; Female; Fibronectins; Gene Expression Regulation; Injections, Intramuscular; Integrin alphaVbeta3; Leukemia Inhibitory Factor; Mifepristone; Pregnancy; Progestins; Rats; Rats, Wistar | 2021 |
Progesterone is essential for protecting against LPS-induced pregnancy loss. LIF as a potential mediator of the anti-inflammatory effect of progesterone.
Topics: Animals; Anti-Inflammatory Agents; Dietary Supplements; Embryo Loss; Female; Gene Expression Regulation; Leukemia Inhibitory Factor; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Mifepristone; Nitric Oxide; Pregnancy; Progesterone; Receptors, Progesterone; RNA, Messenger; Uterus | 2013 |
Tamoxifen and RU39411 synergize with mifepristone to produce preimplantation pregnancy loss by increasing embryo transport (rat).
Topics: Abortifacient Agents, Steroidal; Administration, Oral; Animals; Blastocyst; Corpus Luteum; Drug Combinations; Drug Synergism; Embryo Implantation; Embryo Loss; Embryonic Development; Estradiol; Estrogen Antagonists; Female; Mifepristone; Pregnancy; Rats; Rats, Wistar; Tamoxifen; Time Factors | 1996 |